Ultima Genomics is focused on driving the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company’s new sequencing architecture lowers the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth, and frequency with which they use genomic information.
Ultima’s new sequencing architecture is designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information, and catalyze the next phase of genomics in the 21st century.
K Health developed a data-driven digital primary care platform to use the power of shared medical knowledge to get everyone access to better, affordable healthcare.
The K Health platform uses artificial intelligence to help people understand how those with similar symptoms and conditions were diagnosed and treated. Its platform consolidates the knowledge of thousands of doctors and billions of clinical data insights to get people trusted information and treatment fast.
K Health also offers, through affiliated professional entities, the option to chat with a clinician without insurance for less than a copay. K Health treats hundreds of urgent and primary care conditions, as well as anxiety and depression, and offers remote custom treatment plans and prescriptions.
Immunai is developing a proprietary data set of multi-omic, immune-centric peripheral tissue analyses. The company's advanced analytics and data-visualization interface allows researchers to comprehensively view and interrogate data and to derive novel conclusions on the underlying mechanisms of disease.
The platform is currently being used to develop and refine cell therapies for neuroblastoma in conjunction with the Baylor College of Medicine.
Viz.ai provides multidisciplinary care teams with alerts early in the workflow process to connect frontline health care professionals with specialists and facilitate efficient communication and care coordination. Powered by AI, Viz.ai replaces outdated, conventional care practices with a single platform, enabling care teams to save time, reduce leakage, and improve patient quality of life.
The company’s products include the Viz LVO and Viz CTP platforms. Both are FDA cleared and commercially available in the United States. The Viz LVO uses artificial intelligence to automatically detect LVO strokes and triage patients directly to a stroke specialist. The Viz CTP uses advanced processing technology to automatically analyze CT perfusion images and generate parametric perfusion color maps.
Empowering Physicians to Improve Patient Outcomes with AI
Aidoc is a pioneering force in clinical AI focusing on aiding and empowering healthcare teams to optimize patient treatment, resulting in improved economic value and clinical outcomes.
Powered by Aidoc’s exclusive aiOS, the company analyzes and aggregates medical data that enables care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Aidoc AI is always on, running in the background to change the foreground.
Digital Therapeutics for Treating Chronic Conditions
DarioHealth is a global digital therapeutics company aiming to revolutionize how people with chronic conditions manage their health, with offerings that include highly rated diabetes and hypertension solutions.
The companys AI-powered digital therapeutic solutions are designed to do more than simply support an individuals disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, high-quality software, coaching, and intuitive, clinically proven digital tools to help individuals improve their health and sustain meaningful outcomes.
DarioHealth operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets using a performance-based approach to improve its users health.